CIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets

Tsai, Shengdar Q, Nguyen, Nhu T, Malagon-Lopez, Jose, Topkar, Ved V, Aryee, Martin J, Joung, J Keith·2017·Nature Methods
DOI 10.1038/nmeth.4278

Cited by (816)

Items 201–300 of 816

  1. TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor
    Jeonghun Kwon, Minyoung Kim, Seung-Min Bae, Anna Jo, Young-Ho Kim, Jungjoon K. Lee · 2022 · Nature Communications
  2. CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
    Francesco Chemello, Eric N. Olson, Rhonda Bassel‐Duby · 2023 · Human Gene Therapy
  3. Genome-wide detection of DNA double-strand breaks by in-suspension BLISS
    Britta A. M. Bouwman, Federico Agostini, Silvano Garnerone, Giuseppe Petrosino, Henrike Johanna Gothe, Sergi Sayols, Andreas E. Moor, Shalev Itzkovitz, Magda Bienko, Vassilis Roukos et al. · 2020 · Nature Protocols
  4. Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
    Hemangi G. Chaudhari, Jon N Penterman, Holly J. Whitton, Sarah J. Spencer, Nicole Flanagan, Maria C. Lei Zhang, Elaine Huang, Aditya S. Khedkar, J. Mike Toomey, Courtney A. Shearer et al. · 2020 · The CRISPR Journal
  5. HMEJ-based safe-harbor genome editing enables efficient generation of cattle with increased resistance to tuberculosis
    Mengke Yuan, Jingcheng Zhang, Yuanpeng Gao, Zikun Yuan, Zhenliang Zhu, Yongke Wei, Teng Wu, Jing Han, Yong Zhang · 2021 · Journal of Biological Chemistry
  6. Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies
    Shuming Yin, Mei Zhang, Yang Liu, Xiaoyue Sun, Yuting Guan, Xi Chen, Lei Yang, Yanan Huo, Jing Yang, Xiaohui Zhang et al. · 2022 · Molecular Therapy
  7. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders
    Sudhanshu P. Raikwar, Nidhi Shankar Kikkeri, Ragha Chaitanya Sakuru, Daniyal Saeed, Haris Zahoor, Keerthivaas Premkumar, Shireen Mentor, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed et al. · 2019 · Journal of Neuroimmune Pharmacology
  8. Genome Editing for Mucopolysaccharidoses
    Édina Poletto, Guilherme Baldo, Natalia Gomez‐Ospina · 2020 · International Journal of Molecular Sciences
  9. Translating CRISPR-Cas Therapeutics: Approaches and Challenges
    Lavina Sierra Tay, Nathan D. Palmer, Rebecca Panwala, Wei Leong Chew, Prashant Mali · 2020 · The CRISPR Journal
  10. CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data
    Ido Amit, Ortal Iancu, Alona Levy-Jurgenson, Gavin Kurgan, Matthew McNeill, Garrett R. Rettig, Daniel G. Allen, Dor Breier, Nimrod Ben Haim, Yu Wang et al. · 2021 · Nature Communications
  11. Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34(+) hematopoietic stem and progenitor cells
    Cromer, M. Kyle, Majeti, Kiran R., Rettig, Garrett R., Murugan, Karthik, Kurgan, Gavin L., Bode, Nicole M., Hampton, Jessica P., Vakulskas, Christopher A., Behlke, Mark A., Porteus, Matthew H. · 2023 · Molecular Therapy
  12. Massively targeted evaluation of therapeutic CRISPR off-targets in cells
    Pan, Xiaoguang, Qu, Kunli, Yuan, Hao, Xiang, Xi, Anthon, Christian, Pashkova, Liubov, Liang, Xue, Han, Peng, Corsi, Giulia I., Xu, Fengping et al. · 2022 · Nature Communications
  13. AI-generated MLH1 small binder improves prime editing efficiency
    Ju-Chan Park, Heesoo Uhm, Yong Woo Kim, Ye Eun Oh, Jeung‐Hee Lee, Jiyun Yang, Kyoungmi Kim, Sangsu Bae · 2025 · Cell
  14. Personalised genome editing – The future for corneal dystrophies
    Tara Moore, Kathleen A. Christie, John Marshall, M. Andrew Nesbit · 2018 · Progress in Retinal and Eye Research
  15. Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes
    Liyang Zhang, H. Tomas Rube, Christopher A. Vakulskas, Mark A. Behlke, Harmen J. Bussemaker, Miles A. Pufall · 2020 · Nucleic Acids Research
  16. Knockout of the HMG domain of the porcine SRY gene causes sex reversal in gene-edited pigs
    Stefanie Kurtz, Andrea Lucas‐Hahn, Brigitte Schlegelberger, Gudrun Göhring, Heiner Niemann, Thomas C. Mettenleiter, Björn Petersen · 2020 · Proceedings of the National Academy of Sciences
  17. Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
    Jakob M. Domm, Sarah K. Wootton, Jeffrey A. Medin, Michael L. West · 2021 · Molecular Genetics and Metabolism
  18. Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects
    Karl Petri, Daniel Y. Kim, Kanae E. Sasaki, Matthew C. Canver, Xiao Wang, Hina Shah, Hyunho Lee, Joy E. Horng, Kendell Clement, Sowmya Iyer et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
    Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, Najmeh Heshmatpour, Sarita R. Patnaik · 2024 · Frontiers in Genome Editing
  20. Therapeutic genome editing in cardiovascular diseases
    Masataka Nishiga, Lei S. Qi, Joseph C. Wu · 2020 · Advanced Drug Delivery Reviews
  21. GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
    Erwei Zuo, Yidi Sun, Wei Wu, Tanglong Yuan, Wenqin Ying, Hao Sun, Liyun Yuan, Lars Michael Steinmetz, Yixue Li, Hui Yang · 2020 · Nature Protocols
  22. Negative DNA supercoiling induces genome-wide Cas9 off-target activity
    Matthew D. Newton, Marialucrezia Losito, Quentin M. Smith, Nishita Parnandi, Benjamin J. Taylor, Pınar Akçakaya, Marcello Maresca, Patrick van Eijk, Simon Huw Reed, Simon J. Boulton et al. · 2023 · Molecular Cell
  23. CRISPRoffT: comprehensive database of CRISPR/Cas off-targets
    Grant Wang, Xiaona Liu, Aoqi Wang, Jianguo Wen, Pora Kim, Qianqian Song, Xiaona Liu, Xiaobo Zhou · 2024 · Nucleic Acids Research
  24. Identifying genome-wide off-target sites of CRISPR RNA–guided nucleases and deaminases with Digenome-seq
    Daesik Kim, Beum‐Chang Kang, Jin‐Soo Kim · 2021 · Nature Protocols
  25. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells
    Byung‐Chul Lee, Richard J. Lozano, Cynthia E. Dunbar · 2021 · Molecular Therapy
  26. A kinetic model predicts SpCas9 activity, improves off-target classification, and reveals the physical basis of targeting fidelity
    Behrouz Eslami-Mossallam, Misha Klein, Constantijn P. van der Smagt, Koen van der Sanden, Stephen K. Jones, John A. Hawkins, Ilya J. Finkelstein, Martin Depken · 2022 · Nature Communications
  27. Paving the way towards precise and safe CRISPR genome editing
    Paweł Śledziński, Magdalena Dabrowska, Mateusz Nowaczyk, Marta Olejniczak · 2021 · Biotechnology Advances
  28. R-CRISPR: A Deep Learning Network to Predict Off-Target Activities with Mismatch, Insertion and Deletion in CRISPR-Cas9 System
    Rui Niu, Jiajie Peng, Zhipeng Zhang, Xuequn Shang · 2021 · Genes
  29. Building CRISPR Gene Therapies for the Central Nervous System
    Sally E. Salomonsson, Claire Dudley Clelland · 2024 · JAMA Neurology
  30. Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells
    Josh Tycko, Luis Alberto Barrera, Nicholas C. Huston, Ari E. Friedland, Xuebing Wu, Jonathan S. Gootenberg, Omar O. Abudayyeh, Vic E. Myer, Christopher J. Wilson, Patrick D. Hsu · 2018 · Nature Communications
  31. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency
    Cheng-Han Chung, Alexander G. Allen, Neil T. Sullivan, Andrew Atkins, Michael R. Nonnemacher, Brian L. Wigdahl, Will Dampier · 2019 · Molecular Therapy
  32. Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
    Ziyi Zhao, Chenxi Li, Fei Tong, Jingkuang Deng, Guofu Huang, Yi Sang · 2021 · Biological Procedures Online
  33. Precision digital mapping of endogenous and induced genomic DNA breaks by INDUCE-seq
    Felix M. Dobbs, Patrick van Eijk, Mick D. Fellows, Luisa Loiacono, Roberto Nitsch, Simon Huw Reed · 2022 · Nature Communications
  34. Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    M. Kyle Cromer, Valentin V. Barsan, Erich B. Jaeger, Mengchi Wang, Jessica P. Hampton, Feng Chen, Drew Kennedy, Jenny Xiao, Irina Khrebtukova, Ana Granat et al. · 2022 · Nature Communications
  35. T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds
    Manuel Rhiel, Kerstin Geiger, Geoffroy Andrieux, Julia Rositzka, Melanie Boerries, Toni Cathomen, Tatjana I. Cornu · 2023 · Frontiers in Genome Editing
  36. Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo
    Katarina Kulhánková, Soumba Traore, Xue Cheng, Hadrien Benk-Fortin, Stéphanie Hallée, Mario Harvey, Joannie Roberge, Frédéric Couture, Sajeev Kohli, Thomas J Gross et al. · 2023 · Nature Communications
  37. Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Bernice Ling Zhi Oh, Natasha Vinanica, Desmond Wong, Dario Campana · 2024 · Haematologica
  38. CRISPR-Cap: multiplexed double-stranded DNA enrichment based on the CRISPR system
    Jeewon Lee, Hyeonseob Lim, Hoon Sik Jang, Byungjin Hwang, Joon Ho Lee, Junhyuk Cho, Ji Hyun Lee, Duhee Bang · 2018 · Nucleic Acids Research
  39. Therapeutic gene editing in haematological disorders with CRISPR /Cas9
    Trine I. Jensen, Esben Axelgaard, Rasmus Otkjær Bak · 2019 · British Journal of Haematology
  40. Collateral damage and CRISPR genome editing
    Mark Thomas, Gaétan Burgio, David J. Adams, Vivek Iyer · 2019 · PLoS Genetics
  41. Genome Editing
    Kiran Musunuru · 2017 · Journal of the American College of Cardiology
  42. crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays
    Störtz, Florian, Minary, Peter · 2021 · Nucleic Acids Research
  43. Genetic therapies for cystic fibrosis lung disease
    Stephen L. Hart, Patrick T. Harrison · 2017 · Current Opinion in Pharmacology
  44. Synergizing CRISPR/Cas9 off-target predictions for ensemble insights and practical applications
    Shixiong Zhang, Xiangtao Li, Qiuzhen Lin, Ka‐Chun Wong · 2018 · Bioinformatics
  45. Gene therapy and genome editing for primary immunodeficiency diseases
    Zhiyong Zhang, Adrian James Thrasher, Fang Zhang · 2019 · Genes & Diseases
  46. CRISPR-M: Predicting sgRNA off-target effect using a multi-view deep learning network
    Jialiang Sun, Jun Hai Guo, Jian Liu · 2024 · PLoS Computational Biology
  47. Impact of Genetic Variation on CRISPR-Cas Targeting
    Matthew C. Canver, J. Keith Joung, Luca Pinello · 2018 · The CRISPR Journal
  48. mRNA and gene editing: Late breaking therapies in liver diseases
    Nerea Zabaleta, Laura Torella, Nicholas D. Weber, Gloria González‐Aseguinolaza · 2022 · Hepatology
  49. Development of an Efficient C-to-T Base-Editing System and Its Application to Cellulase Transcription Factor Precise Engineering in Thermophilic Fungus Myceliophthora thermophila
    Chenyang Zhang, Nan Li, Lang Rao, Jingen Li, Qian Liu, Chaoguang Tian · 2022 · Microbiology Spectrum
  50. Assessing and engineering the IscB–ωRNA system for programmed genome editing
    Hao Yan, Xiaoqing Tan, Siyuan Zou, Yihong Sun, Ailong Ke, Weixin Tang · 2024 · Nature Chemical Biology
  51. PEAR, a flexible fluorescent reporter for the identification and enrichment of successfully prime edited cells
    Dorottya Anna Simon, András Tálas, Péter István Kulcsár, Zsuzsanna Biczók, Sarah Laura Krausz, György Várady, Ervin Welker · 2022 · eLife
  52. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
    Caleb A. Lareau, Kendell Clement, Jonathan Y. Hsu, Vikram Pattanayak, J. Keith Joung, Martin J. Aryee, Luca Pinello · 2018 · Nature Methods
  53. Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing
    Hsiu‐Hui Tsai, Hsiao‐Jung Kao, Ming-Wei Kuo, Chin‐Hsien Lin, Chun-Min Chang, Yi‐Yin Chen, Hsiao‐Huei Chen, Pui–Yan Kwok, Alice Lin-Tsing Yu, John Yu · 2023 · Nature Communications
  54. Base editing of trinucleotide repeats that cause Huntington’s disease and Friedreich’s ataxia reduces somatic repeat expansions in patient cells and in mice
    Żaneta Matuszek, Mandana Arbab, Maheswaran Kesavan, Alvin Hsu, Jennie C. L. Roy, Jing Zhao, Tian Yu, Ben Weisburd, Gregory A. Newby, Neil J. Doherty et al. · 2025 · Nature Genetics
  55. Clinical genome editing to treat sickle cell disease—A brief update
    Parinaz Zarghamian, Julia Klermund, Toni Cathomen · 2023 · Frontiers in Medicine
  56. Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
    Johannes Bischof, Markus Hierl, Ulrich Koller · 2024 · International Journal of Molecular Sciences
  57. Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation
    Wenliang Zhu, Wan Du, Arun Prabhu Rameshbabu, Ariel Miura Armstrong, Stewart Silver, Yehree Kim, Wei Wei, Yilai Shu, Xuezhong Liu, Morag A. Lewis et al. · 2024 · Science Translational Medicine
  58. Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
    Will Dampier, Neil T. Sullivan, Cheng-Han Chung, Joshua Chang Mell, Michael R. Nonnemacher, Brian L. Wigdahl · 2017 · Scientific Reports
  59. Benchmarking and integrating genome-wide CRISPR off-target detection and prediction
    Jifang Yan, Dongyu Xue, Guohui Chuai, Yuli Gao, Gongchen Zhang, Qi Liu · 2020 · Nucleic Acids Research
  60. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia
    Alexandra C. Chadwick, Kiran Musunuru · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  61. Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
    Duško Lainšček, Vida Forstnerič, Veronika Mikolič, Špela Malenšek, Peter Pečan, Mojca Benčina, Matjaž Sever, Helena Podgornik, Roman Jerala · 2022 · Nature Communications
  62. Current Non-Viral-Based Strategies to Manufacture CAR-T Cells
    Leon Gehrke, Vasco Dos Reis Gonçalves, Dominik Andrae, Tamás Raskó, Patrick Ho, Hermann Einsele, Michael Hudecek, Sabrina R. Friedel · 2024 · International Journal of Molecular Sciences
  63. Prime editing-installed suppressor tRNAs for disease-agnostic genome editing
    Sarah E. Pierce, Steven Erwood, Keyede Oye, Meirui An, Nicholas Andrew Krasnow, Emily Rong Zhang, Aditya Raguram, Davis M. Seelig, Mark J. Osborn, David R. Liu · 2025 · Nature
  64. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells
    Tianwen Li, Linwen Zhu, Bingxiu Xiao, Zhaohui Gong, Qi Liao, Junming Guo · 2018 · Biotechnology Advances
  65. Genome-Wide Off-Target Analysis in CRISPR-Cas9 Modified Mice and Their Offspring
    Dong Yan, Haimei Li, Liang Zhao, Peter A. Koopman, Feng Zhang, Johnny X. Huang · 2019 · G3 Genes Genomes Genetics
  66. Synthetic chimeric nucleases function for efficient genome editing
    Rui Liu, Liya Liang, Emily F. Freed, Hong Yi Chang, Eun Joong Oh, Zeyu Liu, Andrew D. Garst, Carrie A. Eckert, Ryan T. Gill · 2019 · Nature Communications
  67. CReVIS-Seq: A highly accurate and multiplexable method for genome-wide mapping of lentiviral integration sites
    Heon Seok Kim, Gue‐Ho Hwang, Hyomin K. Lee, Taegeun Bae, Seong-Ho Park, Yong Jun Kim, Sun Lee, Jae-Hoon Park, Sangsu Bae, Junho K. Hur · 2021 · Molecular Therapy — Methods & Clinical Development
  68. CRISPR-Cas systems: Challenges and future prospects
    Nisarg Gohil, Gargi Bhattacharjee, Navya Lavina Lam, Samuel David Perli, Vijai Singh · 2021 · Progress in molecular biology and translational science
  69. The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing
    Manuel M. Vicente, Miguel Chaves‐Ferreira, João M. P. Jorge, João T. Proença, Vasco M. Barreto · 2021 · Frontiers in Cell and Developmental Biology
  70. Identification and Characterization of Extrachromosomal Circular DNA in Plasma of Lung Adenocarcinoma Patients
    Xiaoqiong Wu, Pu Li, Maimaitiaili Yimiti, Zhiqiu Ye, Xuqian Fang, Peizhan Chen, Zhidong Gu · 2022 · International Journal of General Medicine
  71. Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1
    Brackett, Nicole F., Davis, Brian W., Adli, Mazhar, Pomés, Anna, Chapman, Martin D. · 2022 · The CRISPR Journal
  72. Engineered CRISPR Systems for Next Generation Gene Therapies
    Michael Pineda, Farzaneh Moghadam, Mo R. Ebrahimkhani, Samira Kiani · 2017 · ACS Synthetic Biology
  73. Illuminating the genome-wide activity of genome editors for safe and effective therapeutics
    Yong Cheng, Shengdar Q. Tsai · 2018 · Genome biology
  74. CRISPR therapy towards an HIV cure
    Elena Herrera-Carrillo, Zongliang Gao, Ben Berkhout · 2019 · Briefings in Functional Genomics
  75. DL-CRISPR: A Deep Learning Method for Off-Target Activity Prediction in CRISPR/Cas9 With Data Augmentation
    Yu Zhang, Yahui Long, Rui Yin, Chee Keong Kwoh · 2020 · IEEE Access
  76. HIV-1 cure strategies: why CRISPR?
    Andrew Atkins, Alexander G. Allen, Will Dampier, Elias K. Haddad, Michael R. Nonnemacher, Brian L. Wigdahl · 2020 · Expert Opinion on Biological Therapy
  77. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing
    Guillermo Aquino‐Jarquín · 2021 · Molecular Genetics and Metabolism
  78. Direct correction of haemoglobin E β-thalassaemia using base editors
    Mohsin Badat, Ayesha Ejaz, Hua Peng, Siobhan Rice, Weijiao Zhang, Lance D. Hentges, Christopher A. Fisher, Nicholas Denny, Ron Schweßinger, Nirmani Yasara et al. · 2023 · Nature Communications
  79. Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases
    Lauren C. Testa, Kiran Musunuru · 2023 · BioDrugs
  80. AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells
    Lupeng Ye, Stanley Z. Lam, Luojia Yang, Kazushi Suzuki, Yongji Zou, Qianqian Lin, Yueqi Zhang, Paul R. Clark, Lei Peng, Sidi Chen · 2023 · Nature Biomedical Engineering
  81. Breaking genetic shackles: The advance of base editing in genetic disorder treatment
    Fang Xu, Caiyan Zheng, Weihui Xu, Shiyao Zhang, Shanshan Liu, Xiaopeng Chen, Kai Yao · 2024 · Frontiers in Pharmacology
  82. The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth
    Fubiao Niu, Marta Kazimierska, Ilja Maria Nolte, Miente Martijn Terpstra, Debora de Jong, Jasper A. Koerts, Tineke van der Sluis, Bea Rutgers, Ryan M. O’Connell, Klaas Kok et al. · 2020 · Cancers
  83. CRISPAltRations: A validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing
    Gavin Kurgan, Rolf Turk, Heng Li, Nathan Roberts, Garrett R. Rettig, Ashley M. Jacobi, Lauren Tso, Morgan L. Sturgeon, Massimo Mertens, Roel Noten et al. · 2021 · Molecular Therapy — Methods & Clinical Development
  84. Linking CRISPR–Cas9 double-strand break profiles to gene editing precision with BreakTag
    Gabriel M. C. Longo, Sergi Sayols, Andriana G. Kotini, Sabine Heinen, Martin M. Möckel, Petra Beli, Vassilis Roukos · 2024 · Nature Biotechnology
  85. A versatile CRISPR/Cas9 system off-target prediction tool using language model
    Weian Du, Liang Zhao, Kaichuan Diao, Yangyang Zheng, Qianyong Yang, Zhenzhen Zhu, Xiangxing Zhu, Dongsheng Tang · 2025 · Communications Biology
  86. Trinucleotide repeat instability during double-strand break repair: from mechanisms to gene therapy
    Valentine Mosbach, Lucie Poggi, Guy‐Franck Richard · 2018 · Current Genetics
  87. Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
    Hongxin Huang, Yongfei Hu, Guanjie Huang, Shufeng Ma, Jianqi Feng, Dong Wang, Ying Lin, Jiajian Zhou, Zhili Rong · 2021 · Communications Biology
  88. Off- and on-target effects of genome editing in mouse embryos
    Shinya Ayabe, Kenichi NAKASHIMA, Atsushi Yoshiki · 2018 · Journal of Reproduction and Development
  89. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance
    Keun-Tae Kim, Ju-Chan Park, Hyeon‐Ki Jang, Haeseung Lee, Seokwoo Park, Jumee Kim, Ok‐Seon Kwon, Young-Hyun Go, Yan Jin, Wankyu Kim et al. · 2020 · Biomaterials
  90. Engineering a New Generation of Gene Editors: Integrating Synthetic Biology and AI Innovations
    Bing Shao Chia, Samantha Seah, Bolun Wang, Kimberle Shen, Diya Srivastava, Wei Leong Chew · 2025 · ACS Synthetic Biology
  91. Genome editing in maize and sorghum: A comprehensive review of CRISPR/Cas9 and emerging technologies
    Mercy Jocyline Namata, Jingyi Xu, Ephrem Habyarimana, Sudhakar Reddy Palakolanu, Lihua Wang, Jieqin Li · 2025 · The Plant Genome
  92. CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
    Seung Hwan Lee, Young‐Ho Park, Yeung Bae Jin, Sun‐Uk Kim, Junho K. Hur · 2019 · Trends in Molecular Medicine
  93. Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients
    Neil T. Sullivan, Will Dampier, Cheng-Han Chung, Alexander G. Allen, Andrew Atkins, Vanessa Pirrone, Greg Homan, Shendra R. Passic, Jean W. Williams, Wen Zhong et al. · 2019 · Scientific Reports
  94. Genetic authentication: Differentiation of fine and bulk cocoa (Theobroma cacao L.) by a new CRISPR/Cas9-based in vitro method
    Alexandra Scharf, Christina Lang, Markus J. Fischer · 2020 · Food Control
  95. Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells
    Mihaela Zabulica, Tomas Jakobsson, Francesco Ravaioli, Massoud Vosough, Roberto Gramignoli, Ewa C. S. Ellis, Olav Rooyackers, Stephen C. Strom · 2021 · International Journal of Molecular Sciences
  96. New Frontiers: Precise Editing of Allergen Genes Using CRISPR
    Nicole F. Brackett, Anna Pomés, Martin D. Chapman · 2022 · Frontiers in Allergy
  97. Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
    Hui Meng, Manman Nan, Yizhen Li, Yi Ding, Yuhui Yin, Mingzhi Zhang · 2023 · Frontiers in Endocrinology
  98. Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes
    Mihaela Zabulica, Raghuraman C. Srinivasan, Pınar Akçakaya, Gabriella Allegri, Burcu Bestas, Mike A. Firth, Christina Hammarstedt, Tomas Jakobsson, Towe Jakobsson, Ewa C. S. Ellis et al. · 2021 · Molecular Therapy
  99. Advances in the gene therapy of monogenic blood cell diseases
    Juan Antonio Bueren, Oscar Quintana Bustamante, Elena Almarza, Susana Navarro, Paula Rı́o, Jose Carlos Segovia, Guillermo Güenechea · 2019 · Clinical Genetics
  100. Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
    Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Guillermo Ureña-Bailén, Janani Raju, Justin S. Antony, Rupert Handgretinger, Markus Mezger · 2019 · Blood Reviews